BioAge Labs (BIOA) Receivables - Accured (2024 - 2026)

BioAge Labs (BIOA) has 3 years of Receivables - Accured data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Accured rose 72.73% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 72.73% YoY), and the FY2025 full-year result was $1.2 million, changed 0.0% from the prior year.
• Receivables - Accured climbed to $1.9 million in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Receivables - Accured ranged from a high of $1.9 million in Q1 2026 to a low of $1.0 million in Q2 2025.
• A 3-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Receivables - Accured.
• Across the five-year window, Receivables - Accured changed 0.0% in 2025 and soared 72.73% in 2026, its largest moves.
• Tracing BIOA's Receivables - Accured over 3 years: stood at $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then soared by 58.33% to $1.9 million in 2026.
• Business Quant data shows BIOA's Receivables - Accured at $1.9 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.